A. Labelle

990 total citations · 1 hit paper
3 papers, 785 citations indexed

About

A. Labelle is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, A. Labelle has authored 3 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Psychiatry and Mental health, 1 paper in Pharmacology and 1 paper in Cognitive Neuroscience. Recurrent topics in A. Labelle's work include Schizophrenia research and treatment (2 papers), Functional Brain Connectivity Studies (1 paper) and Neural dynamics and brain function (1 paper). A. Labelle is often cited by papers focused on Schizophrenia research and treatment (2 papers), Functional Brain Connectivity Studies (1 paper) and Neural dynamics and brain function (1 paper). A. Labelle collaborates with scholars based in Canada, United States and United Kingdom. A. Labelle's co-authors include B. Jones, Guy Chouinard, Gary Remington, D. M. Bloom, Donald Addington, G. William MacEwan, Linda Beauclair, Wendy Arnott, Colleen Mahoney and Verner Knott and has published in prestigious journals such as Schizophrenia Research and Journal of Clinical Psychopharmacology.

In The Last Decade

A. Labelle

3 papers receiving 731 citations

Hit Papers

A Canadian Multicenter Placebo-Controlled Study of Fixed ... 1993 2026 2004 2015 1993 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Labelle Canada 3 623 181 130 127 124 3 785
Joseph McEvoy United States 7 838 1.3× 274 1.5× 130 1.0× 231 1.8× 53 0.4× 13 1.0k
Mihai Gheorghe Romania 4 802 1.3× 219 1.2× 129 1.0× 188 1.5× 67 0.5× 4 910
P.V. Tran United States 7 938 1.5× 230 1.3× 258 2.0× 174 1.4× 54 0.4× 15 1.2k
O. Fleurot France 8 715 1.1× 146 0.8× 256 2.0× 112 0.9× 45 0.4× 22 797
Barringer D. Marshall United States 13 761 1.2× 220 1.2× 124 1.0× 234 1.8× 244 2.0× 31 942
S. Heylen Belgium 7 452 0.7× 96 0.5× 97 0.7× 94 0.7× 99 0.8× 11 560
R. Tamura United States 8 865 1.4× 203 1.1× 236 1.8× 173 1.4× 36 0.3× 30 1.1k
Dennis Sweitzer United States 11 672 1.1× 102 0.6× 196 1.5× 142 1.1× 37 0.3× 13 833
Stuart Kushner United States 14 1.0k 1.7× 96 0.5× 119 0.9× 250 2.0× 117 0.9× 19 1.2k
Mary Anne Dellva United States 16 831 1.3× 171 0.9× 236 1.8× 185 1.5× 33 0.3× 44 1.3k

Countries citing papers authored by A. Labelle

Since Specialization
Citations

This map shows the geographic impact of A. Labelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Labelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Labelle more than expected).

Fields of papers citing papers by A. Labelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Labelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Labelle. The network helps show where A. Labelle may publish in the future.

Co-authorship network of co-authors of A. Labelle

This figure shows the co-authorship network connecting the top 25 collaborators of A. Labelle. A scholar is included among the top collaborators of A. Labelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Labelle. A. Labelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Knott, Verner, A. Labelle, B. Jones, & Colleen Mahoney. (2001). Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment. Schizophrenia Research. 50(1-2). 41–53. 76 indexed citations
2.
Purdon, Scot E., et al.. (2000). Neuropsychological change in schizophrenia after 6 months of double-blind treatment with quetiapine or haloperidol. Schizophrenia Research. 41(1). 205–206. 5 indexed citations
3.
Chouinard, Guy, B. Jones, Gary Remington, et al.. (1993). A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients. Journal of Clinical Psychopharmacology. 13(1). 25???40–25???40. 704 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026